Telmiprime Trio 40mg/5mg/12.5mg Tablet
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmiprime Trio 40mg/5mg/12.5mg Tablet
Tri-Med Hypertension 40mg/5mg/12.5mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Tri-Med Hypertension can be administered with or without food; dosage is individualized based on patient response and condition. Consistent daily timing is recommended. Continue taking this medication as directed by your physician. Due to its diuretic component, which increases urination, avoid taking it within four hours of bedtime. Regular use, even during periods of well-being, is crucial for optimal benefit, as hypertension often presents asymptomatically. Discontinuing treatment may significantly increase stroke or heart attack risk. Common side effects include fatigue, headache, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to minimize potential side effects such as dry mouth, muscle weakness, and excessive thirst. Prior to commencing treatment, inform your physician about any pre-existing kidney or liver conditions, pregnancy, or breastfeeding. Always disclose all current medications, particularly those for cardiovascular or hypertension management. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood sugar is essential to ensure treatment efficacy.
Uses of Telmiprime Trio 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telmiprime Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmiprime Trio 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telmiprime Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmiprime Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 40mg/5mg/12.5mg Telmiprime Trio Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, however, consistent daily timing is recommended.
How Telmiprime Trio 40mg/5mg/12.5mg Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide (40mg/5mg/12.5mg) are combined in Telmiprime Trio tablets to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and Amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, reducing blood pressure. The diuretic Hydrochlorothiazide promotes fluid excretion, lowering blood volume and further contributing to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Telmiprime Trio 40mg/5mg/12.5mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Telmiprime Trio 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
The combination drug Telmiprime Trio (40mg/5mg/12.5mg tablets) is contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Telmiprime Trio 40mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headaches, nausea, or fatigue. These side effects can reduce concentration and impact driving safety.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Telmiprime Trio 40mg/5mg/12.5mg tablets requires careful consideration and potential dosage modification. A physician's consultation is advised. Patients with severe kidney disease should generally avoid Telmiprime Trio 40mg/5mg/12.5mg tablets.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Telmiprime Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmiprime Trio 40mg/5mg/12.5mg Tablet :
Should you forget a Telmiprime Trio 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmiprime Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




